Drug Shortage Report for ACT MELOXICAM
Report ID | 102935 |
Drug Identification Number | 02250012 |
Brand name | ACT MELOXICAM |
Common or Proper name | MELOXICAM 7.5MG |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MELOXICAM |
Strength(s) | 7.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | M01AC |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-01-08 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-01-09 |
Company comments | item is To Be Disc |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-01-09 | French | Compare |
v1 | 2020-01-09 | English | Compare |
Showing 1 to 2 of 2